-Economic and Political Weekly Ten years on, the progressive provisions of the amended Indian Patents Act are being watered down. Ten years have passed since the Indian Patents Act, 1970 was amended in 2005 to bring the country’s laws in line with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The most important of the 2005 amendments was the introduction of product patents for 20 years, including for pharmaceutical products,...

-Down to Earth   HIV/AIDS, suicide among other top causes. The good news is that rates of cigarette smoking are decreasing in 10-19 years age group in some countries A report released by World Health Organization (WHO) on Wednesday says depression is the predominant cause of illness and disability for both boys and girls aged 10 to 19 years. The top three causes of global adolescent deaths are road traffic injuries, HIV/AIDS, and...

-The Indian Express Food inflation owes largely to agricultural markets being regulated by outdated laws. The RBI governor, Raghuram Rajan, has a difficult task this week. He has to decide whether to keep interest rates constant or raise them - bearing in mind the possible taper of the US Fed's bond buying programme, a decline in industrial production and a rise in inflation. The sharp increase in consumer price-based inflation, to more...

-The Hindu The south leads in the number of medical and nursing seats, with for-profit private colleges dominating the scene. It will take major capacity expansion in the government sector to meet WHO norms on access to health professionals. India has achieved major organisational and technological successes but the health system's performance is abysmal. This cannot be attributed to poverty. It is poor health that places India 134th in the Human Development...

-The Business Standard The Novartis verdict by the Supreme Court emphasised the importance of flexibilities in drug patent laws, in contrast to Western countries which are seeking TRIPS-plus hardening through free-trade agreements As curtains on the six-year-long legal tussle with Swiss drug giant Novartis AG finally came down earlier this month, the Indian government did not waste a second in hailing the Indian patent law which it said was in "full...